Registered entities
Astex Pharmaceuticals, Inc.
Reg. No. 911841574United States
Astex Therapeutics Limited
Reg. No. 3751674United Kingdom
Innovation
22 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 2,226 times.
| Year | Filings |
|---|---|
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 3 |
Investor mix
8 investors on record; lead investors include New Enterprise Associates.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 88% |
| Private equity | 1 | 13% |